Cognoa
Overview
Cognoa develops artificial intelligence and machine learning solutions for early detection and assessment of neurodevelopmental conditions, particularly autism spectrum disorder in children. The company leverages digital biomarkers and behavioral analysis to provide clinicians and families with objective diagnostic tools and clinical decision support.
More in Neurotechnology
Latest industry news
China's Neurotech Ambitions Signal a New Frontier in the Global Brain Race
2026-10-18 · Industry
Functional Ultrasound BCIs Cross a Threshold: From Brain Reading to Two-Way Control
2026-10-17 · Research
Visual Cues Are Quietly Skewing BCI Accuracy Scores, and the Field Is Taking Notice
2026-10-16 · Research
ReVision Implant Secures €4 Million to Advance Neural Vision Restoration Technology
2026-10-15 · Funding
Company details
Category
🏢 Neurotechnology
Funding
Private
Listed
2026-07-10
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →